Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537963 · ClinicalTrials.gov registry record · NA
Improving Sleep in BMT Survivors
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03537963 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 30 participants.
The verdict
NCT03537963, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to: To test a new intervention for sleep disturbance among hematopoietic cell transplant survivors. About 60 hematopoietic cell transplant (HCT) survivors will participate in this intervention. Preliminary Steps: To conduct qualitative interviews with patients, caregivers, and clinicians regarding sleep disturbance in hematopoietic cell transplant (HCT) survivors and on preferences for a new mHealth intervention for sleep disturbance. About 30 individuals (10 HCT survivors, 10 caregivers and 5-10 clinicians) will participate in this part of the study.
Interventions
- OTHER Interview
- OTHER Questionnaire
- OTHER Qualitative Interviews
- OTHER mHealth Stepped-care Intervention
- OTHER Educational Control Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-15 |
| Est. Completion | 2024-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03537963
The ClinicalTrials.gov registry entry for NCT03537963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Interview is the first listed.
NCT03537963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03537963 about?
NCT03537963 is a clinical study titled "Improving Sleep in BMT Survivors". The purpose of this study is to: To test a new intervention for sleep disturbance among hematopoietic cell transplant survivors. About 60 hematopoietic cell transplant (HCT) survivors will participate in this intervention. Preliminary Steps: To conduct qualitative interviews with patients, caregiv...
What is the current status of trial NCT03537963?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-05-15. Estimated completion is 2024-04-19.
What interventions are being tested in trial NCT03537963?
The interventions under investigation include: Interview (OTHER), Questionnaire (OTHER), Qualitative Interviews (OTHER), mHealth Stepped-care Intervention (OTHER), Educational Control Condition (OTHER).
Who is sponsoring clinical trial NCT03537963?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.